Cambridge University's needle-free coronavirus vaccine begins clinical trials in home city

The vaccine – known as DIOS-CoVax – has been developed by Professor Jonathan Heeney at the University of Cambridge and spin-out company DIOSynVax. It is

Related Keywords

United Kingdom ,Cambridge ,Cambridgeshire ,Jonathan Heeney ,Management Team ,Southampton Clinical Research Facility ,United Kingdom Research ,University Of Cambridge ,Darwin College ,Cambridge University Hospitals ,Professor Jonathan Heeney ,Clinical Research Facility ,Project Management Team ,Innovate United Kingdom ,Cambridge Enterprise ,Diosynvax Jonathan Heeney Coronavirus ,Covid 19 ,Potlight On Future Therapeutics ,Potlight On Innovation ,Vaccine Coronavirus ,Vaccine ,Potlight On Innovation Cambridge Enterprise ,Cambridge Infectious Diseases ,Cambridge University Hospitals Nhs Foundation Trust ,Laboratory Of Viral Zoonotics ,School Of The Biological Sciences ,Epartment Of Veterinary Medicine School The Biological Sciences ,Department Of Veterinary Medicine ,